SCHEMBL15445449

SCHEMBL15445449

Cc1c(C(=O)CO)ccc2cccnc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
EGLN1 Q9GZT9 12/20 0.47
LMNA P02545 3/20 0.46
KDM4E B2RXH2 2/20 0.46
MAPT P10636 2/20 0.46
HTT P42858 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
GMNN O75496 1/20 0.46
TP53 P04637 1/20 0.46
HSP90AA1 P07900 1/20 0.46
MMP2 P08253 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
MMP9 P14780 1/20 0.46
ALOX15 P16050 1/20 0.46
TSHR P16473 1/20 0.46
NFKB1 P19838 1/20 0.46
MMP8 P22894 1/20 0.46
CCR1 P32246 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15445450 0.83 ALDH1A1 (0.69) ALDH1A1EGLN1
SCHEMBL13943232 0.82 ALDH1A1 (0.54) ALDH1A1EGLN1LMNAKDM4EMAPT
SCHEMBL644794 0.82 ALDH1A1 (0.68) ALDH1A1EGLN1LMNAKDM4EMAPT
SCHEMBL3502575 0.78 KDM4E (0.56) ALDH1A1EGLN1LMNAKDM4EHTT
SCHEMBL23714060 0.78 EGLN1 (0.56) ALDH1A1EGLN1KDRNPC1CASP3
SCHEMBL14136247 0.77 ALDH1A1 (0.49) ALDH1A1EGLN1LMNAKDM4EMAPT
SCHEMBL9983599 0.77 ALDH1A1 (0.49) ALDH1A1EGLN1LMNAKDM4EMAPT
SCHEMBL18069879 0.77 ALDH1A1 (0.49) ALDH1A1EGLN1KDM4EMAPTHTT
SCHEMBL643192 0.74 ALDH1A1 (0.46) ALDH1A1EGLN1LMNAKDM4EMAPT
SCHEMBL13065799 0.73 KDM4E (0.52) ALDH1A1LMNAKDM4EMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140031355-A1 HETEROCYCLIC COMPOUNDS AND THEIR USES AMGEN INC. (US) 2014-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140031355-A1 HETEROCYCLIC COMPOUNDS AND THEIR USES MCL1, SSB, MALT1 ALDH1A1 3702/4885EGLN1 2256/4885LMNA 2393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.